Neuropace

+$0.09 (+1.73%) As of 1:42 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neuropace and other ETFs, options, and stocks.

About NPCE

NeuroPace, Inc. develops, manufactures and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components which include the RNS neurostimulator as well as depth and cortical strip leads.

CEO
Michael Favet
Employees
166
Headquarters
Mountain View, California
Founded
1997

NPCE Key Statistics

Market cap
130.16M
Price-Earnings ratio
—
Dividend yield
—
Average volume
122.41K
High today
$5.29
Low today
$5.29
Open price
$5.29
Volume
290.00
52 Week high
$25.26
52 Week low
$4.61

NPCE Earnings

-$21.26
-$14.17
-$7.09
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure